Investing.com - Merck&Co reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Merck&Co announced earnings per share of $1.32 on revenue of $12.51B. Analysts polled by Investing.com anticipated EPS of $1.38 on revenue of $12.67B.
Merck&Co shares are down 5% from the beginning of the year and are trading at $77.32 , down-from-52-week-high.They are under-performing the Dow Jones which is up 0.38% from the start of the year.
Merck&Co follows other major Healthcare sector earnings this month
Merck&Co's report follows an earnings beat by J&J on Tuesday, January 26, 2021, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Abbott Labs had beat expectations on Wednesday, January 27, 2021 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar